Literature DB >> 2280583

[Regression of cerebral post-transplantation lymphoma under cyclosporin A reduction].

M Fric1, A Hartmann, H U Klehr, U Pfeifer, C Herberhold.   

Abstract

4.5 months after successful kidney transplantation a Non-Hodgkin-lymphoma with polymorph centroblastic appearance of the tonsillar gland developed in a 21 years old male patient during immunosuppressive therapy with cyclosporine A and prednisone parallel to infection with Epstein Barr virus. Focal epileptic seizures occurred and were due to cerebral posttransplantation lymphomas as proven by brain biopsy. Reduction of immunosuppressive therapy led to complete remission as shown by CCT and MRI.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2280583     DOI： 10.1007/bf01815278

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  12 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-1987. A 50-year-old woman with a central nervous system disorder and renal failure two months after a renal transplant.

Authors: 
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

Review 2.  Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

Authors:  T E Starzl; I Penn; C W Putnam; C G Groth; C G Halgrimson
Journal:  Transplant Rev       Date:  1971

3.  Immunosuppression and malignant neoplasms.

Authors:  R L Simmons; J S Najarian
Journal:  N Engl J Med       Date:  1970-10-22       Impact factor: 91.245

4.  Immunosuppression and malignant neoplasms.

Authors:  T E Starzl; I Penn; C G Halgrimson
Journal:  N Engl J Med       Date:  1970-10-22       Impact factor: 91.245

5.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

6.  Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.

Authors:  G Klein; D Purtilo
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Malignant lymphomas in transplantation patients.

Authors:  I Penn; W Hammond; L Brettschneider; T E Starzl
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

8.  Skin cancer in Caucasian renal allograft recipients living in a subtropical climate.

Authors:  I R Hardie; R W Strong; L C Hartley; P W Woodruff; G J Clunie
Journal:  Surgery       Date:  1980-02       Impact factor: 3.982

9.  Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.

Authors:  A H Wilkinson; J L Smith; L G Hunsicker; J Tobacman; D P Kapelanski; M Johnson; F H Wright; D M Behrendt; R J Corry
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

10.  Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

Authors:  G Frizzera; D W Hanto; K J Gajl-Peczalska; J Rosai; R W McKenna; R K Sibley; K P Holahan; L L Lindquist
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701
View more
  1 in total

1.  An instructive false diagnosis: steroid-induced complete remission of a CNS tumor--probably lymphoma.

Authors:  J G Heckmann; J Bockhorn; M Stolte; A Druschky; B Neundörfer
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.